Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China flag China · Delayed Price · Currency is CNY
17.12
-0.13 (-0.75%)
Apr 16, 2026, 10:00 AM CST

SHA:601607 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
57,53859,21569,39656,10760,07249,277
Market Cap Growth
-10.05%-14.67%23.68%-6.60%21.91%3.75%
Enterprise Value
85,57587,41595,55580,06581,07576,701
Last Close Price
17.2517.7420.5415.9616.5217.97
PE Ratio
11.2010.3415.2414.8910.699.68
Forward PE
11.7722.1222.418.0814.0410.35
PS Ratio
0.200.210.250.220.260.23
PB Ratio
0.640.660.830.700.770.83
P/TBV Ratio
1.061.091.261.101.211.54
P/FCF Ratio
15.0315.4720.2524.8229.1852.28
P/OCF Ratio
9.359.6211.9110.7312.679.74
PEG Ratio
--1.510.671.170.84
EV/Sales Ratio
0.300.310.350.310.350.36
EV/EBITDA Ratio
7.648.368.687.948.378.55
EV/EBIT Ratio
10.1110.3310.269.339.9310.27
EV/FCF Ratio
22.3522.8327.8935.4139.3981.38
Debt / Equity Ratio
0.640.640.650.650.570.69
Debt / EBITDA Ratio
5.115.114.664.824.294.24
Debt / FCF Ratio
14.9514.9515.9522.9621.6743.25
Net Debt / Equity Ratio
0.160.160.120.140.100.31
Net Debt / EBITDA Ratio
1.351.350.931.120.782.05
Net Debt / FCF Ratio
3.693.693.004.973.6919.49
Asset Turnover
1.251.251.271.271.281.38
Inventory Turnover
6.016.016.486.456.557.32
Quick Ratio
0.970.971.020.980.990.93
Current Ratio
1.341.341.361.331.351.27
Return on Equity (ROE)
8.04%8.04%7.16%6.53%10.20%11.03%
Return on Assets (ROA)
2.33%2.33%2.69%2.61%2.82%2.99%
Return on Invested Capital (ROIC)
5.78%6.07%7.35%7.09%7.95%7.85%
Return on Capital Employed (ROCE)
8.60%8.60%9.80%9.60%9.30%10.40%
Earnings Yield
9.95%9.67%6.56%6.72%9.35%10.34%
FCF Yield
6.65%6.46%4.94%4.03%3.43%1.91%
Dividend Yield
2.76%2.65%1.80%2.57%3.69%2.34%
Payout Ratio
48.91%48.91%79.16%105.66%55.08%52.54%
Buyback Yield / Dilution
-0.11%-0.11%-0.07%-6.28%-22.54%-
Total Shareholder Return
2.64%2.53%1.73%-3.71%-18.85%2.34%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.